STANLEY H APPEL M.D.
Prescription History 1124009113
Psychiatry & Neurology - Neurology in Houston, TX

NPI Status: Active since November 08, 2005

Contact Information

6560 FANNIN
SUITE 802
HOUSTON, TX
ZIP 77030
Phone: (713) 441-3760
Fax: (713) 793-7271

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for STANLEY H APPEL M.D., an active Neurology specialist practicing in Houston, TX. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 404 documented patient claims. Among these therapy options, the most frequently utilized medication is Riluzole, which accounts for 159 claims alone.

Medication Index

No matching medications currently found on file.

Baclofen

Generic Formulation: BaclofenSpecialty: Neurology
Provider Metrics Summary
Total Claims 23
30-Day Fills 31.2
Days Supply 908
TX State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills55.5
Peer Average Days Supply1,537
Conservative Utilization

This provider writes prescriptions for this formulation 43.9% less frequently than the standard regional baseline metric for practitioners inside TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $394.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.14

State Avg Cost Per Claim

$27.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Nuedexta

Generic Formulation: Dextromethorphan Hbr/QuinidineSpecialty: Neurology
Provider Metrics Summary
Total Claims 62
30-Day Fills 74.0
Days Supply 2,220
TX State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills33.0
Peer Average Days Supply637
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 100.0% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $113,657.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,833.19

State Avg Cost Per Claim

$977.89

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain mental/mood disorder (pseudobulbar affect). This disorder may occur due to various conditions that affect the brain (such as stroke, amyotrophic lateral sclerosis-ALS, multiple sclerosis). This medication may help decrease sudden outbursts of uncontrollable/inappropriate laughing and/or crying. This medication is a combination of 2 ingredients: dextromethorphan and quinidine. Dextromethorphan works in the brain, though it is not known exactly how it helps treat pseudobulbar affect. Quinidine is added to this medication to increase the effect of dextromethorphan.

Radicava Ors

Generic Formulation: EdaravoneSpecialty: Neurology
Provider Metrics Summary
Total Claims 106
30-Day Fills 106.0
Days Supply 2,968
TX State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills26.7
Peer Average Days Supply745
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 307.7% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,546,216.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$14,586.95

State Avg Cost Per Claim

$14,470.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE.

Therapeutic Applications

Edaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). It helps to slow down the worsening of this disease. However, it is not a cure for ALS, and it does not reverse nerve damage or muscle weakness.

Relyvrio

Generic Formulation: Sod Phenylbutyrat/TaurursodiolSpecialty: Neurology
Provider Metrics Summary
Total Claims 54
30-Day Fills 54.0
Days Supply 1,512
TX State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills17.0
Peer Average Days Supply476
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 217.6% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $663,851.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$12,293.54

State Avg Cost Per Claim

$10,254.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). This medication contains 2 drugs: sodium phenylbutyrate and taurursodiol (also known as ursodoxicoltaurine). It helps slow down loss of physical function due to this disease. However, it is not a cure for ALS, and it does not reverse nerve damage or muscle weakness.

Riluzole

Generic Formulation: RiluzoleSpecialty: Neurology
Provider Metrics Summary
Total Claims 159
30-Day Fills 369.0
Days Supply 11,070
TX State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills57.7
Peer Average Days Supply1,713
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 381.8% higher than the standard regional baseline profile for TX. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $29,717.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$186.90

State Avg Cost Per Claim

$258.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Therapeutic Applications

This medication is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). Riluzole helps to slow down the worsening of this disease and prolong survival.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like STANLEY H APPEL M.D. provides transparency into local medical care patterns within Houston, TX.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.